Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice

Cell Host Microbe. 2021 Aug 11;29(8):1249-1265.e9. doi: 10.1016/j.chom.2021.06.014. Epub 2021 Jul 21.

Abstract

Early-life antibiotic exposure perturbs the intestinal microbiota and accelerates type 1 diabetes (T1D) development in the NOD mouse model. Here, we found that maternal cecal microbiota transfer (CMT) to NOD mice after early-life antibiotic perturbation largely rescued the induced T1D enhancement. Restoration of the intestinal microbiome was significant and persistent, remediating the antibiotic-depleted diversity, relative abundance of particular taxa, and metabolic pathways. CMT also protected against perturbed metabolites and normalized innate and adaptive immune effectors. CMT restored major patterns of ileal microRNA and histone regulation of gene expression. Further experiments suggest a gut-microbiota-regulated T1D protection mechanism centered on Reg3γ, in an innate intestinal immune network involving CD44, TLR2, and Reg3γ. This regulation affects downstream immunological tone, which may lead to protection against tissue-specific T1D injury.

Keywords: NOD mice; animal models; autoimmune; cecal material transfer; gene expression; histone modification; innate immune; microRNA; microbiome; type 1 diabetes.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Autoimmune Diseases
  • Bacteria / classification
  • Bacteria / drug effects
  • Cecum / immunology*
  • Cecum / microbiology*
  • Diabetes Mellitus, Type 1 / immunology*
  • Disease Models, Animal
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology*
  • Gene Expression
  • Histone Code
  • Intestines / immunology
  • Male
  • Metabolic Networks and Pathways
  • Metagenome
  • Mice
  • Mice, Inbred NOD
  • MicroRNAs

Substances

  • Anti-Bacterial Agents
  • MicroRNAs